Applying Desirability of Outcome Ranking End Points
Clin Infect Dis
.
2023 Jul 5;77(1):159-161.
doi: 10.1093/cid/ciad166.
Authors
Michael W Dunne
1
,
Steven I Aronin
1
,
Anita F Das
2
,
Jayanti Gupta
1
,
Karthik Akinapelli
3
,
Michael T Zelasky
4
,
Sailaja Puttagunta
1
,
Helen W Boucher
5
Affiliations
1
Iterum Therapeutics, Old Saybrook, Connecticut, USA.
2
Das Statistical Consulting, Guerneville, California, USA.
3
Takeda Pharmaceuticals, Cambridge, Massachusetts, USA.
4
Johnson & Johnson, Cambridge, Massachusetts, USA.
5
Tufts Medicine and Tufts University School of Medicine, Boston, Massachusetts, USA.
PMID:
36974506
PMCID:
PMC10320050
DOI:
10.1093/cid/ciad166
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Grants and funding
Iterum Therapeutics